DE69918431D1 - Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris - Google Patents

Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris

Info

Publication number
DE69918431D1
DE69918431D1 DE69918431T DE69918431T DE69918431D1 DE 69918431 D1 DE69918431 D1 DE 69918431D1 DE 69918431 T DE69918431 T DE 69918431T DE 69918431 T DE69918431 T DE 69918431T DE 69918431 D1 DE69918431 D1 DE 69918431D1
Authority
DE
Germany
Prior art keywords
lower alkyl
general formula
discloses
compounds
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918431T
Other languages
English (en)
Other versions
DE69918431T2 (de
Inventor
Swastik Park Sankaranarayanan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrent Pharmaceuticals Ltd
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of DE69918431D1 publication Critical patent/DE69918431D1/de
Application granted granted Critical
Publication of DE69918431T2 publication Critical patent/DE69918431T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69918431T 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris Expired - Fee Related DE69918431T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (de) 1998-05-22 1998-05-22
INCA093598 1998-05-22
PCT/IB1999/000892 WO1999061430A1 (en) 1998-05-22 1999-05-17 Benzofuroxan derivatives and their use in treating angina pectoris

Publications (2)

Publication Number Publication Date
DE69918431D1 true DE69918431D1 (de) 2004-08-05
DE69918431T2 DE69918431T2 (de) 2005-07-14

Family

ID=11085434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69918431T Expired - Fee Related DE69918431T2 (de) 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
DE69909782T Expired - Lifetime DE69909782D1 (de) 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69909782T Expired - Lifetime DE69909782D1 (de) 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris

Country Status (16)

Country Link
US (2) US6248895B1 (de)
EP (2) EP1079829B1 (de)
JP (2) JP3378239B2 (de)
CN (2) CN1302205A (de)
AT (2) ATE270279T1 (de)
AU (2) AU3623299A (de)
BR (2) BR9910637A (de)
CA (2) CA2333001A1 (de)
CZ (1) CZ20004072A3 (de)
DE (2) DE69918431T2 (de)
ES (1) ES2222029T3 (de)
HU (2) HUP0102057A3 (de)
IN (1) IN188837B (de)
PT (1) PT1080081E (de)
RU (2) RU2209065C2 (de)
WO (2) WO1999061018A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (de) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-hemmer mit antioxidativer und no-donor-wirkung
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) * 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
WO2010000019A1 (en) * 2008-07-02 2010-01-07 The University Of Queensland Pain-relieving compositions of furoxan no donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions
CN104592145B (zh) * 2015-01-15 2017-05-17 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Also Published As

Publication number Publication date
EP1080081B1 (de) 2004-06-30
HUP0101584A3 (en) 2002-12-28
AU3623299A (en) 1999-12-13
BR9910637A (pt) 2001-02-06
CZ20004072A3 (cs) 2001-08-15
CN1302205A (zh) 2001-07-04
WO1999061018A1 (en) 1999-12-02
WO1999061430A1 (en) 1999-12-02
IN188837B (de) 2002-11-09
PT1080081E (pt) 2004-10-29
ATE245419T1 (de) 2003-08-15
BR9910628A (pt) 2001-01-30
JP2002516275A (ja) 2002-06-04
EP1080081A1 (de) 2001-03-07
CN1301258A (zh) 2001-06-27
ES2222029T3 (es) 2005-01-16
JP2002516317A (ja) 2002-06-04
EP1079829A1 (de) 2001-03-07
EP1079829B1 (de) 2003-07-23
RU2222532C2 (ru) 2004-01-27
HUP0102057A3 (en) 2002-12-28
RU2209065C2 (ru) 2003-07-27
US6232331B1 (en) 2001-05-15
US6248895B1 (en) 2001-06-19
HUP0102057A2 (hu) 2001-11-28
ATE270279T1 (de) 2004-07-15
HUP0101584A2 (hu) 2001-11-28
CA2333001A1 (en) 1999-12-02
DE69909782D1 (de) 2003-08-28
AU3623399A (en) 1999-12-13
JP3378239B2 (ja) 2003-02-17
CA2332950A1 (en) 1999-12-02
DE69918431T2 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
DE69918431D1 (de) Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
NO176840C (no) Analogifremgangsmåte for fremstilling av 2,9-disubstituerte-4H-pyrido[1,2-aÅpyrimidin-4-oner
DE69125216T2 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
DE69215694D1 (de) Benzamid-derivate
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
KR970702845A (ko) 신규의 히드록시믹산 유도체, 그를 포함한 약제학적 조성물 및 그의 제조방법
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
DE68914600T2 (de) Kondensierte heterocyclische Derivate von 1,2,3,4-Tetrahydroacridin, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE69021664T2 (de) Verwendung von bisphenol-Derivaten zur Behandlung von Diabetes mellitus.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
HUP0100750A2 (hu) Új 6-szulfamoil-3-kinolilfoszfonsav származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
KR950017956A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee